CDK Inhibitors approved by PBAC 20 April 2018
CDK Inhibitors approved by the Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue. See the link below for further information https://www.bcna.org.au/news/2018/04/cdk-i...
Forum Discussion
SO very pleased to hear and read the news, will be a game changer for those women who will soon be able to afford this drug ,just a bit sad that it looks like it will only be for those as a first line of treatment, and that I will not be able to access them, I will discuss with my oncologist when I see him next month, perhaps by then we will have a clearer picture of who can and who cannot have them.
wendy55
wendy55